By vgreene, 8 May, 2020 Asymptomatic HCPs w/ recognized COVID-19 exposure might be permitted to work in crisis capacity strategy if they wear facemask for source control for 14 days after exposure (based on incubation period)
By vgreene, 8 May, 2020 Facilities must prepare for potential shortages and have plans in place to mitigate them, including considerations for permitting HCPs to return to work w/o meeting all criteria above
By vgreene, 8 May, 2020 Self-monitor for sx; seek re-eval from occupation health if resp sx recur/worsen
By vgreene, 8 May, 2020 Wear facemask or cloth face covering for source control at all times until sx completely resolved or at baseline. After this, revert to facility policy re: universal source control. Note: A facemask doesn’t replace N95 or higher respirator. N95 or other r
By vgreene, 8 May, 2020 If asymptomatic HCP w/ lab-confirmed COVID-19, use either a time-based or test-based strategy (either acceptable depending on local circumstances)
By vgreene, 8 May, 2020 Test-based strategy: Exclude from work until negative results of FDA Emergency Use Authorized COVID-19 molecular assay for SARS-CoV-2 RNA from ≥2 consecutive resp specimens collected ≥24h apart4
By vgreene, 8 May, 2020 Time-based strategy: Exclude from work until 10 days1 have passed since date of 1st positive COVID-19 test assuming no subsequent development of sx since positive test. If sx develop, use sx-based or test-based strategy3
By vgreene, 8 May, 2020 Negative results of FDA Emergency Use Authorized COVID-19 molecular assay for SARS-CoV-2 RNA2 from ≥2 consecutive resp specimens collected ≥24h apart